UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

PloS one, 2022-07, Vol.17 (7), p.e0271036-e0271036

2022

Volltextzugriff (PDF)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic

International journal of infectious diseases, 2023-07, Vol.132, p.72-79

2023

Volltextzugriff (PDF)

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

EClinicalMedicine, 2020-09, Vol.26, p.100525-100525, Article 100525

2020

Volltextzugriff (PDF)

Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism

PloS one, 2015-04, Vol.10 (4), p.e0125057-e0125057

2015

Volltextzugriff (PDF)

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

Vaccines (Basel), 2022-02, Vol.10 (2), p.291

2022

Volltextzugriff (PDF)

Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Vaccine, 2022-01, Vol.40 (3), p.428-431

2022

Volltextzugriff (PDF)

Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Vaccine, 2022-01, Vol.40 (3), p.428-431

2022

Volltextzugriff (PDF)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019

Clinical infectious diseases, 2023-10, Vol.77 (7), p.964-971

2023

Volltextzugriff (PDF)

Management of thrombocytopenia

F1000 prime reports, 2014-06, Vol.6, p.45-45

2014

Volltextzugriff (PDF)

Long‐term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)

British journal of haematology, 2020-04, Vol.189 (2), p.379-382

2020

Volltextzugriff (PDF)

Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Blood, 2013-11, Vol.122 (21), p.3628-3628

2013

Volltextzugriff (PDF)

Qualifying coronavirus disease 2019 convalescent plasma donors in Israel

Vox sanguinis, 2022-02, Vol.117 (2), p.185-192

2022

Volltextzugriff (PDF)

Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection

Vox sanguinis, 2023-07, Vol.118 (7), p.517-522

2023

Volltextzugriff (PDF)

COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA

הרפואה, 2021-03, Vol.160 (3), p.139

2021

Volltextzugriff (PDF)

Contemporary treatment of immune thrombocytopenia

Expert Review of Hematology, 2013-12, Vol.6 (6), p.697-712

2013

Volltextzugriff (PDF)

Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture

Blood, 2014-12, Vol.124 (21), p.5114-5114

2014

Volltextzugriff (PDF)

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Blood, 2017-12, Vol.130, p.5368-5368

2017

Volltextzugriff (PDF)

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary

Vox sanguinis, 2021-11, Vol.116 (10), p.1117-1135

2021

Volltextzugriff (PDF)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients

Clinical infectious diseases, 2023-05

2023

Volltextzugriff (PDF)

Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b

Blood, 2014-12, Vol.124 (21), p.4190-4190

2014

Volltextzugriff (PDF)

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

PloS one, 2022-01, Vol.17 (7), p.e0271036

2022

Volltextzugriff (PDF)

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

Blood, 2013-11, Vol.122 (21), p.2310-2310

2013

Volltextzugriff (PDF)

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

Vox sanguinis, 2021-11, Vol.116 (10), p.e71-e120

2021

Volltextzugriff (PDF)

Identification of Aldolase as a Target Antigen in Alzheimer's Disease

The Journal of immunology (1950), 2005-09, Vol.175 (5), p.3439-3445

2005

Volltextzugriff (PDF)

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Blood, 2014-12, Vol.124 (21), p.4409-4409

2014

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(14)
Humans
(10)
Covid-19
(8)
Hematology
(6)
Antibodies
(5)
Coronaviruses
(5)
Female
(5)
Plasma
(5)
Sars-Cov-2
(5)
Severe Acute Respiratory Syndrome Coronavirus 2
(5)
Covid-19 Vaccines
(4)
Immunoglobulin G
(4)
Immunology
(4)
Pandemics
(4)
Convalescent Plasma
(3)
Covid-19 - Therapy
(3)
Immunization
(3)
Immunization, Passive
(3)
Infectious Diseases
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Actin inhibition increases megakaryocyte proplatelet formation through an apoptosis-dependent mechanism

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

Correlation of Anti-SARS-CoV-2 S1-specific IgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019

Management of thrombocytopenia

Long‐term sustained response to fostamatinib in two patients with chronic refractory immune thrombocytopenia (ITP)

Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Qualifying coronavirus disease 2019 convalescent plasma donors in Israel

Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection

COVID-19 - BLOOD GROUPS, ANTIBODIES AND CONVALESCENT PLASMA

Contemporary treatment of immune thrombocytopenia

Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary

A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients

Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy

Rituximab Combined With Three Cycles Of High Dose Dexamethasone Provides a Long Term Response Rate Similar To That Of Splenectomy In Patients With Immune Thrombocytopenia (ITP) Of Duration Less Than 2 Years

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

Identification of Aldolase as a Target Antigen in Alzheimer's Disease

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Suchergebnisse filtern